Mercedes Jimenez*, Nuria E. Campillo* and Matilde Canelles Pages 3964 - 3979 ( 16 )
In December 2019, a novel respiratory coronavirus named SARS-CoV-2 appeared in China, causing the disease termed COVID-19 that has caused millions of infections worldwide. In this article, we have analyzed existing evidence on the immune response against SARS coronaviruses in order to understand the possible outcome of a vaccine for COVID-19. From our analysis, it becomes clear that there is a big difference in the immune response against SARS in children, young adults and the elderly, both at the innate and adaptive levels. Taking this information into account, we have studied the strategies that are being used for the development of COVID-19 vaccines. We discussed the perspectives for obtention and worldwide distribution of reliable vaccines using this perspective. The conclusion is that different vaccines may be protective for different age segments within the population, depending on the strategy used for their design. Therefore, it will become necessary for several vaccines to reach the finish line, not only to ensure availability, but also to guarantee an adequate immune response at the individual level.
COVID-19, SARS-CoV-2, infection, coronavirus immune response, vaccine development, vaccine phases.
Centro de Investigaciones Biologicas Margarita Salas (CIB-CSIC), Ramiro de Maeztu 9, 28040 Madrid, Centro de Investigaciones Biologicas Margarita Salas (CIB-CSIC), Ramiro de Maeztu 9, 28040 Madrid, Instituto de Filosofía, (IFS-CSIC), Albasanz 26, 28037 Madrid